Antares pharma to participate in the h.c. wainwright 23rd annual global investment conference

Ewing, n.j., sept. 08, 2021 (globe newswire) -- antares pharma, inc. (nasdaq: atrs) (“the company”), a specialty pharmaceutical company, today announced that robert f. apple, president and chief executive officer, will participate and host investor meetings at the h.c. wainwright 23rd annual global investment conference being held on september 13-15, 2021.
ATRS Ratings Summary
ATRS Quant Ranking